The potential of PARP as a therapeutic target across pediatric solid malignancies.
Saved in:
| Title: | The potential of PARP as a therapeutic target across pediatric solid malignancies. |
|---|---|
| Authors: | Keller KM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Koetsier J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Schild L; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Amo-Addae V; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Eising S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van den Handel K; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Ober K; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Koopmans B; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Essing A; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van den Boogaard ML; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Langenberg KPS; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Jäger N; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany., Kool M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany., Pfister S; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany., Dolman MEM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Children's Cancer Institute, Lowy Cancer Centre, UNSW Sydney, Kensington, NSW, Australia.; School of Women's and Children's Health, Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. j.j.molenaar@prinsesmaximacentrum.nl.; Department of Pharmaceutical Sciences, University Utrecht, Utrecht, the Netherlands. j.j.molenaar@prinsesmaximacentrum.nl., van Hooff SR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. |
| Source: | BMC cancer [BMC Cancer] 2023 Apr 05; Vol. 23 (1), pp. 310. Date of Electronic Publication: 2023 Apr 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-2407 |
|---|---|
| DOI: | 10.1186/s12885-022-10319-7 |
